Paper33334065
Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression.
Wang WL and 7 others. Cancers (Basel), 2020. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression. Papers, record 33334065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33334065
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOST-107-2320-B-004-009-MY3 | Ministry of Sciences and Technology in Taiwan | PubMed | ||
| CSH-2019-C-027 | Chung Shan Medical University Hospital | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24753943 | Factors predicting recurrent endometrial cancer. | Facts Views Vis Obgyn | 2013 | https://conductscience.org/library/papers/24753943 | PubMed |
| 2 | 12439748 | Abnormalities of the APC/beta-catenin pathway in endometrial cancer. | Oncogene | 2002 | https://conductscience.org/library/papers/12439748 | PubMed |
| 3 | 28393700 | Mammalian Pseudokinase TRIB3 in Normal Physiology and Disease: Charting the Progress in Old and New Avenues. | Curr Protein Pept Sci | 2017 | https://conductscience.org/library/papers/28393700 | PubMed |
| 4 | 26748468 | Manual evaluation of tissue microarrays in a high-throughput research project: The contribution of Indian surgical pathology to the Human Protein Atlas (HPA) project. | Proteomics | 2016 | https://conductscience.org/library/papers/26748468 | PubMed |
| 5 | 30551640 | Targeting Cancer Stem Cells to Overcome Chemoresistance. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30551640 | PubMed |
| 6 | 18322269 | Cadherin switching. | J Cell Sci | 2008 | https://conductscience.org/library/papers/18322269 | PubMed |
| 7 | 28254229 | Incidence and lifetime risk of uterine corpus cancer in Taiwanese women from 1991 to 2010. | Taiwan J Obstet Gynecol | 2017 | https://conductscience.org/library/papers/28254229 | PubMed |
| 8 | 18187772 | TRB3 suppresses adipocyte differentiation by negatively regulating PPARgamma transcriptional activity. | J Lipid Res | 2008 | https://conductscience.org/library/papers/18187772 | PubMed |
| 9 | 25748930 | The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? | Cell Stem Cell | 2015 | https://conductscience.org/library/papers/25748930 | PubMed |
| 10 | 26025765 | Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. | Eur J Cancer | 2015 | https://conductscience.org/library/papers/26025765 | PubMed |
| 11 | 19479054 | NKX2-5 regulates the expression of beta-catenin and GATA4 in ventricular myocytes. | PLoS One | 2009 | https://conductscience.org/library/papers/19479054 | PubMed |
| 12 | 21896644 | TRB3 interacts with SMAD3 promoting tumor cell migration and invasion. | J Cell Sci | 2011 | https://conductscience.org/library/papers/21896644 | PubMed |
| 13 | 20844001 | Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression. | Endocrinology | 2010 | https://conductscience.org/library/papers/20844001 | PubMed |
| 14 | 27935083 | Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort. | Int J Cancer | 2017 | https://conductscience.org/library/papers/27935083 | PubMed |
| 15 | 24400868 | Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1. | J Cell Mol Med | 2014 | https://conductscience.org/library/papers/24400868 | PubMed |
| 16 | 26527320 | Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs. | Oncotarget | 2016 | https://conductscience.org/library/papers/26527320 | PubMed |
| 17 | 23171881 | Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. | Am J Epidemiol | 2013 | https://conductscience.org/library/papers/23171881 | PubMed |
| 18 | 27908682 | Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease. | Trends Cell Biol | 2017 | https://conductscience.org/library/papers/27908682 | PubMed |
| 19 | 14681364 | The Eukaryotic Promoter Database EPD: the impact of in silico primer extension. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/14681364 | PubMed |
| 20 | 2544306 | Determination of subcutaneous tumor size in athymic (nude) mice. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2544306 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41287970 | ELF4/TRIB3/CDK6 Axis Promotes Cancer Stem Cell Activity in Endometrial Cancer. | J Cell Physiol | 2025 | https://conductscience.org/library/papers/41287970 | PubMed |
| 40083328 | Transcription factor ELF4 in physiology and diseases: Molecular roles and clinical implications. | Genes Dis | 2025 | https://conductscience.org/library/papers/40083328 | PubMed |
| 39791220 | Tribbles pseudokinase 3 drives cancer stemness in oral squamous cell carcinoma cells by supporting the expression levels of SOX2 and EGFR. | Int J Mol Med | 2025 | https://conductscience.org/library/papers/39791220 | PubMed |
| 39665272 | The Lyn/RUVBL1 Complex Promotes Colorectal Cancer Liver Metastasis by Regulating Arachidonic Acid Metabolism Through Chromatin Remodeling. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39665272 | PubMed |
| 37880674 | Identification of the role of endoplasmic reticulum stress genes in endometrial cancer and their association with tumor immunity. | BMC Med Genomics | 2023 | https://conductscience.org/library/papers/37880674 | PubMed |
| 37600328 | Comprehensive analysis of E47‑like factors and verification of ELF4 in clear cell renal cell carcinoma. | Oncol Lett | 2023 | https://conductscience.org/library/papers/37600328 | PubMed |
| 37509210 | Pseudokinases, Tribbles Proteins and Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37509210 | PubMed |
| 37266867 | Novel insights into tumorigenesis and prognosis of endometrial cancer through systematic investigation and validation on mitophagy-related signature. | Hum Cell | 2023 | https://conductscience.org/library/papers/37266867 | PubMed |
| 36923538 | FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC. | Theranostics | 2023 | https://conductscience.org/library/papers/36923538 | PubMed |
| 36362068 | Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36362068 | PubMed |
| 35659728 | Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35659728 | PubMed |
| 35024437 | Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers. | Mol Ther Oncolytics | 2022 | https://conductscience.org/library/papers/35024437 | PubMed |
Genes59
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33334065
GET https://conductscience.org/api/papers/v1/33334065/references?page=2